Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Vaccine Effectiveness × Gynecologic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 35 Ovarian Neoplasms 31 Endometrial Neoplasms 12 Uterine Cervical Dysplasia 10 Papillomavirus Infections 9 Breast Neoplasms 9 Uterine Neoplasms 7 Ovarian Cysts 6 Lung Neoplasms 6 Stomach Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Polycystic Ovary Syndrome 3 Ovarian Hyperstimulation Syndrome 3 Neoplasms 3 Liver Neoplasms 3 Leiomyoma 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Vomiting 2 Uterine Diseases 2 Urinary Bladder Neoplasms 2 Tobacco Use Disorder 2 Squamous Intraepithelial Lesions 2 Small Cell Lung Carcinoma 2 Recurrence 2 Peritoneal Neoplasms 2 Pancreatic Neoplasms 2

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07256912 2026-03-24

CervALONE

International Agency for Research on Cancer

Phase 4 Not yet recruiting

Vaccine Effectiveness

Data powered by HemOnc (CC BY 4.0) Colophon ⚡